510(k) Report

510(k) · Cleared

Cleared

Bonemedik, and Bonemedik-S

K070897510(k) TraditionalCleared Sep 17, 2007168-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Meta Biomed Co., Ltd. · MQV Filler, Bone Void, Calcium Compound

Cleared on Sep 17, 2007 as substantially equivalent to P860005 (Interpore Intl., 1992) and 4 other predicates after a 168-day review. Its family tree reaches back 7 generations to 1996.

Decided
Sep 17, 2007
Review
168 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
5

Its longest line of descent runs back 7 generations to K960978 (1996). 21 ancestors in all, the oldest P860005 (1992). No later device cites it as a predicate yet.

  1. Root · 7 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 6 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 5 generations backK000515 Pro Osteon 200R Resorbable Bone Graft Substitute, Models 2RG051…Interpore Cross Intl. · 2000
  4. 4 generations backK012751 Healos Bone Graft MaterialOrquest, Inc. · 2001
  5. 3 generations backK043308 Modification to: Healos Bone Graft MaterialDepuy Spine, Inc. · 2005
  6. 2 generations backK051386 Mastergraft Putty Bone Void FillerMedtronic Vascular · 2005
  7. 1 generation backK060917 Kensey Nash Bone Void FillerKensey Nash Corporation · 2006
  8. This deviceK070897 Bonemedik, and Bonemedik-SMeta Biomed Co., Ltd. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−6K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−5K000515Pro Osteon 200R Resorbable Bone Graft Substitute, Models 2RG051, 2RG101…Interpore Cross Intl.2000—
−4K012751Healos Bone Graft MaterialOrquest, Inc.2001—
−3K043308Modification to: Healos Bone Graft MaterialDepuy Spine, Inc.2005—
−2K051386Mastergraft Putty Bone Void FillerMedtronic Vascular2005—
−1K060917Kensey Nash Bone Void FillerKensey Nash Corporation2006—
0 (this device)K070897Bonemedik, and Bonemedik-SMeta Biomed Co., Ltd.2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
199710
199810
199910
200010
200120
200220
200320
200430
FIG. 1 — Lineage of K070897, 1996–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*P860005Pro Osteon Implant 500 Hydroxyapatite Bone Void Filler
Summary page 2
…bstantially equivalent (and nearly identical) to the Interpore, Intl. product, "Pro Osteon Implant 500 products originally cleared under the Premarket Approval system as P860005 and after reclassification cleared under 510(k)s K990131, K980817 and others. Like Pro Osteon 500, BoneMedik and BoneMedik-S are…
Interpore Intl.1992—
*K990131Pro Osteon Implant 500R Resorbable Bone Graft Substitute
Summary page 2
…rpore, Intl. product, "Pro Osteon Implant 500 products originally cleared under the Premarket Approval system as P860005 and after reclassification cleared under 510(k)s K990131, K980817 and others. Like Pro Osteon 500, BoneMedik and BoneMedik-S are based on natural product that provides the unique structu…
Interpore Cross Intl.1999—
*K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10…
Summary page 2
…tl. product, "Pro Osteon Implant 500 products originally cleared under the Premarket Approval system as P860005 and after reclassification cleared under 510(k)s K990131, K980817 and others. Like Pro Osteon 500, BoneMedik and BoneMedik-S are based on natural product that provides the unique structure. BoneM…
Interpore Intl.1998—
*K060917Kensey Nash Bone Void Filler
Summary page 2
…that provides the unique structure. BoneMedik and BoneMedik-S are also substantially equivalent to the Kensey- Nash Bone Void Filler, cleared by the Kensey Nash Corp. in K060917 and K033679, and several others. The "510(k) "Substantial Equivalence" Decision-Making Process (Detailed) from ODE Guidance Memo…
Kensey Nash Corporation2006—
*K033679Copsios Bone Void Filler (BVF)
Summary page 2
…s the unique structure. BoneMedik and BoneMedik-S are also substantially equivalent to the Kensey- Nash Bone Void Filler, cleared by the Kensey Nash Corp. in K060917 and K033679, and several others. The "510(k) "Substantial Equivalence" Decision-Making Process (Detailed) from ODE Guidance Memorandum #86-3…
Centerpulse Spine-Tech, Inc.2004—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 8 companies; a new generation was cleared every 1.2 years on median.
  • 2 of the 21 ancestors have a recall of any class.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

BoneMedik and BoneMedik-S are indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. They are indicated to be gently packed into bony voids or gaps of the skeletal system (i.e. extremities and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. These products provide a bone graft substitute that resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070897: Bonemedik, and Bonemedik-S.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070897

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026